New long-acting β₂-agonists

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.9, 2004-09, pp. : 1385-1388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

New long acting β₂ agonists

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 273-277

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

By Kim Dennis Glaum Mark Lockey Richard

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Inhaled Long-Acting β 2 -Agonists in the Management of Obstructive Pulmonary Disease

By Sovani Milind P. Whale Christopher I. Tattersfield Anne. E.

Drug Safety, Vol. 27, Iss. 10, 2004-01 ,pp. : 689-715

Adis International

Access to resources Recommend Favorite

Long-Acting β2-Agonists in Asthma: Not so SMART?

By Currie Graeme P.

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 647-656

Adis International

Access to resources Recommend Favorite